- Home
- Automated
- List of product information
- ACTAPIN TABLET 5MG [SIN13537P]
ACTAPIN TABLET 5MG [SIN13537P]
Active ingredients: ACTAPIN TABLET 5MG
Last updated 26 October 2025
On this page
Product Info
ACTAPIN TABLET 5MG
[SIN13537P]
Product information
Active Ingredient and Strength | AMLODIPINE BESILATE 6.95 MG EQV AMLODIPINE - 5 MG |
Dosage Form | TABLET |
Manufacturer and Country | PT ACTAVIS INDONESIA - INDONESIA REP OF |
Registration Number | SIN13537P |
Licence Holder | TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD. |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | C08CA01 |
Indications
Hypertension
Chronic Stable angina and/or Prizmetal/variant angina.
Posology
Posology and method of administration
The usual starting dose is 5 mg daily. May if necessary be increased to 10 mg daily. It is not necessary to adjust the dose of amlodipine during co-administration of thiazides, beta-blockers or ACE inhibitors (angiotensin-converting enzymes). Normal dosage regimens are recommended. Amlodipine, used at similar doses in elderly and younger patients, is equally well tolerated. The efficacy and safety in children has not been investigated.
Contraindications
Hypersensitivity to dihydropyridines (amlodipine, nifedipine, felodipine, isradipine). Or any of the excipients.
Pregnancy (see Pregnancy and Lactation – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information)
Severe hypertension.